Clinical Impacts of Structured Robotic Gait Training Programs

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Calgary

About this trial

Background and Rationale:

Walking impairments impacts the 2-3/1000 children who have cerebral palsy1,2, and others unable to walk due to other central nervous system disorders such as a traumatic brain injury. The impacts of this and related impairment impact all aspects of life. The lifelong costs of these is staggering in terms of dollars (over $1 million/child) and health adjusted life years (\~half compared to typically developing populations despite only slightly shorter lifespans). Yet there are currently no effective interventions to treat the fundamental balance impairment that underlie these problems4,5. Early use of robotic gait trainers have shown many benefits6,7, however access to these trainers is limited due to cost, availability, and ease of use within the home. Currently, there are a few options for an overground robotic gait trainer supported by the stability of a walker. The Trexo, is an option designed for use at home or in a community settings, but barriers to access mean that access to this therapy is out of reach for many people who may see benefits.

Research Questions and Objectives:

The aim of this study is to (a) evaluate the feasibility of a clinical robotic gait training program and (b) evaluate the effectiveness of these types of programs in achieving patient, family, and therapist goals. The study will examine adherence to a structured training program to determine if training with a robotic gait trainer in a hospital setting is feasible for the entire length of the designed training program. Goals will be set, a re-evaluation of these goals will be completed following the training program to determine whether or not the clinical program of robotic gait training was successful in helping patients reach the goals set out at the beginning of the program.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

able to fit into Trexo robotic gait trainer (both leg length and weight); height of <~5'6", weight <150 lbs.)

able to fulfill training requirements throughout training period

able to comply with study procedures (assessments, training)

any age

Disqualifiers

those with contraindications to training with a robotic gait trainer (ie. medical condition or recent surgery requiring lower extremity immobilization or weight-bearing restriction (ie. fracture, unstable hip subluxation), medical condition requiring a physical activity restriction (ie. unstable arrythmia), pain or symptomatic hypotension while standing, contracture such that the Trexo Robotic Gait Training does not result in forward movement)

those involved in a potentially confounding intervention (will be discussed case-by-case to determine risk of impacting the study results).

Trial design

Design model

Single group

Treatments tested in this trial

  • Clinical Impacts of Structured Robotic Gait Training Programs

    Device

    All participants will participate in this arm involving 8 weeks of training 2-3 days/week using the Trexo walking device in clinic

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Clinical Impacts of Structured Robotic Gait Training ProgramsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of Sessions Attended

Evaluate the feasibility of using a robotic gait trainer in an out-patient setting by tracking the number of sessions attended by the participants.

Time frame
Approximately 8 weeks
2

Number of Sessions Missed

Evaluate the feasibility of using a robotic gait trainer in an out-patient setting by tracking the number of sessions missed by the participants.

Time frame
Approximately 8 weeks
3

Length of Session

Evaluate the feasibility of using a robotic gait trainer in an out-patient setting by tracking the length of each training session.

Time frame
Approximately 8 weeks
4

Number of steps per session

Evaluate the feasibility of using a robotic gait trainer in an out-patient setting by tracking the number of steps taken by participants in each session.

Time frame
Approximately 8 weeks

Secondary outcomes

1

Canadian Occupational Performance Measure (COPM)

Evaluate the effectiveness of these types of programs in achieving patient, family, and therapist goals, ranked on a 10-point scale (1-10) for performance and satisfaction.

Time frame
Approximately 8 weeks
2

Goal Attainment Scaling (GAS)

Evaluate the effectiveness of these types of programs in achieving patient, family, and therapist goals, ranked on a 5-point scale from -2 to 2 where the midpoint (0) is typically set as baseline and changes are scored based on objectively measured outcomes.

Time frame
Approximately 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.